Fig. 8: The role of lipid peroxidation and its key regulator, GPX4, in osteoblasts-mediated bone formation.

Phospholipid peroxidation in osteoblasts plays a pivotal role in postmenopausal osteoporosis, driven by diminished estrogen-regulated GPX4 expression. The lipid peroxidation byproduct 4-HNEÂ disrupts RUNX2 signaling through the degradation of ILK. While the natural GPX4 activators 6- and 8-Gingerols promote osteoblastogenesis and demonstrate significant anti-osteoporotic effects.